• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Antisense Therapeutics Ltd

+ Add to Watchlist


0.0702 USD 0.0078 10.00%

As of 20:10:02 ET on 01/06/2015.

Snapshot for Antisense Therapeutics Ltd (ATHJF)

Open: 0.0670 Day's Range: 0.0670 - 0.0702 Volume: 6,750
Previous Close: 0.0780 52wk Range: 0.0670 - 0.2200 1-Yr Rtn: -

Stock Chart for ATHJF

No chart data available.
  • ATHJF:US 0.0702
  • 1D
  • 1M
  • 1Y
Interactive ATHJF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ATHJF

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 11.34
Shares Outstanding (M) 161.49
30 Day Average Volume 825
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/24/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ATHJF

  • Revenue
  • Net Income (M/AUD)
  • Profit Margin (%)

Company Profile & Key Executives for ATHJF

Antisense Therapeutics Limited develops and markets drugs for treatment of diseases like psoriasis, multiple sclerosis, autoimmune, cancer, metabolic and cardiovascular. The drugs are based on small synthetic genetic molecules. The Company has collaboration with Isis Pharmaceuticals in the United States, which provides the Company access to drug development technology.

Mark P DiamondCEO/Managing DirectorPhillip HainsCFO/Secretary
More Company Profile & Key Executives for ATHJF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil